141 related articles for article (PubMed ID: 31939068)
1. Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine.
Nakayama M; Tanaka N; Yamashita J; Iwasaki K
Cardiovasc Interv Ther; 2020 Oct; 35(4):371-378. PubMed ID: 31939068
[TBL] [Abstract][Full Text] [Related]
2. Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
Inoue K; Sonoda S; Naka Y; Okabe H; Setoyama K; Miura T; Anai R; Araki M; Kataoka M
Int Heart J; 2021 Sep; 62(5):962-969. PubMed ID: 34544970
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the risk factors for ventricular arrhythmias secondary to QT prolongation induced by papaverine injection during coronary flow reserve studies using a 4 Fr angio-catheter.
Okabe Y; Otowa K; Mitamura Y; Murai H; Usui S; Kaneko S; Takamura M
Heart Vessels; 2018 Nov; 33(11):1358-1364. PubMed ID: 29713819
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve.
Nishi T; Kitahara H; Iwata Y; Fujimoto Y; Nakayama T; Takahara M; Sugimoto K; Kobayashi Y
J Cardiol; 2016 Dec; 68(6):512-516. PubMed ID: 26811149
[TBL] [Abstract][Full Text] [Related]
5. Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.
Verdoia M; Erbetta R; Sagazio E; Barbieri L; Negro F; Suryapranata H; Kedhi E; De Luca G;
Int J Cardiol; 2019 Jun; 284():16-21. PubMed ID: 30293665
[TBL] [Abstract][Full Text] [Related]
6. Duration of Hyperemia With Intracoronary Administration of Papaverine.
Mizukami T; Sonck J; Gallinoro E; Kodeboina M; Canvedra A; Nagumo S; Bartunek J; Wyffels E; Vanderheyden M; Shinke T; De Bruyne B; Collet C
J Am Heart Assoc; 2021 Feb; 10(3):e018562. PubMed ID: 33459027
[No Abstract] [Full Text] [Related]
7. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study.
Leone AM; Porto I; De Caterina AR; Basile E; Aurelio A; Gardi A; Russo D; Laezza D; Niccoli G; Burzotta F; Trani C; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
JACC Cardiovasc Interv; 2012 Apr; 5(4):402-8. PubMed ID: 22516396
[TBL] [Abstract][Full Text] [Related]
8. Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate.
Nakayama M; Chikamori T; Uchiyama T; Kimura Y; Hijikata N; Ito R; Yuhara M; Sato H; Kobori Y; Yamashina A
Cardiovasc Interv Ther; 2018 Apr; 33(2):116-124. PubMed ID: 28110424
[TBL] [Abstract][Full Text] [Related]
9. Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation.
Goto M; Sato M; Kitazawa H; Takahashi M; Fuse K; Saito A; Okabe M; Aizawa Y
Intern Med; 2014; 53(15):1629-31. PubMed ID: 25088875
[TBL] [Abstract][Full Text] [Related]
10. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment.
Murtagh B; Higano S; Lennon R; Mathew V; Holmes DR; Lerman A
Am Heart J; 2003 Jul; 146(1):99-105. PubMed ID: 12851614
[TBL] [Abstract][Full Text] [Related]
11. Contrast-induced Hyperemia as an Alternative to Drug-induced Hyperemia in the Evaluation of the Fractional Flow Reserve in Coronary Lesions.
Shiode N; Okimoto T; Tamekiyo H; Kawase T; Yamane K; Kagawa Y; Fujii Y; Ueda Y; Hironobe N; Kato Y; Hayashi Y
Intern Med; 2017; 56(3):253-257. PubMed ID: 28154267
[TBL] [Abstract][Full Text] [Related]
12. Effect of QTU prolongation on hyperemic instantaneous wave-free ratio value: a prospective single-center study.
Nakayama M; Uchiyama T; Hijikata N; Kobori Y; Tanaka N; Iwasaki K
Heart Vessels; 2020 Jul; 35(7):909-917. PubMed ID: 31989184
[TBL] [Abstract][Full Text] [Related]
13. Sinus Standstill in a Patient after Intracoronary Papaverine Administration for a Coronary Fractional Flow Reserve.
Nauchi M; Sakai T; Yamawaki M; Ito Y
Int Heart J; 2018 May; 59(3):630-633. PubMed ID: 29681575
[TBL] [Abstract][Full Text] [Related]
14. Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases.
Nakayama M; Saito A; Kitazawa H; Takahashi M; Sato M; Fuse K; Okabe M; Hoshino K; Tanaka N; Yamashina A; Aizawa Y
Intern Med; 2012; 51(4):351-6. PubMed ID: 22333368
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve.
Casella G; Rieber J; Schiele TM; Stempfle HU; Siebert U; Leibig M; Theisen K; Buchmeier U; Klauss V
Z Kardiol; 2003 Aug; 92(8):627-32. PubMed ID: 12955409
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
[TBL] [Abstract][Full Text] [Related]
17. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
[TBL] [Abstract][Full Text] [Related]
18. Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR).
Röther J; Achenbach S; Tröbs M; Blachutzik F; Nef H; Marwan M; Schlundt C
Clin Res Cardiol; 2016 Dec; 105(12):1003-1010. PubMed ID: 27307094
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve.
Rudzinski W; Waller AH; Rusovici A; Dehnee A; Nasur A; Benz M; Sanchez S; Klapholz M; Kaluski E
Catheter Cardiovasc Interv; 2013 Feb; 81(3):540-4. PubMed ID: 22961876
[TBL] [Abstract][Full Text] [Related]
20. Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease.
Aarnoudse W; Geven M; Barbato E; Botman KJ; De Bruyne B; Pijls NH
Am J Cardiol; 2005 Dec; 96(12):1627-30. PubMed ID: 16360347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
